... San Antonio Breast Cancer Symposium, held December 10-13 in San Antonio, Texas. The data demonstrate that the company's CDK2-directed MGD, MRT ...
News
- Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer ...
- Houston Medicine Magazine Headlines Powered By Business Wire
Health | Biotechnology | Pharmaceutical ... View Press Release · Tempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio ...
- Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in ...
(Nasdaq: CELC), a clinical-stage biotechnology company pursuing ... Gonzalez Convention Center in San Antonio, Texas. The poster presents ...
- SABCS: Eli Lilly's oral SERD Ember counts on Verzenio to broaden its glow - Fierce Biotech
Presented at the 2024 San Antonio Breast Cancer Symposium (SABCS), the data support past observations that SERDs tend to perform better in ESR1 ...
- The START Center for Cancer Research Expands its Capabilities to Support Early-Phase ...
SAN ANTONIO, Dec. 10, 2024 /PRNewswire/ -- The START Center for Cancer ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare Disease Deal.